Balance Sheet
Cash Flow Statement
Beginning Cash BalanceChange in Account PayablesCurrent DebtGains from Sales and DivestituresNet Debt Issuances and RepaymentsNon-cash ItemsOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China SXT Pharmaceuticals (SXTC) Change in Account Payables: 2017-2025

Historic Change in Account Payables for China SXT Pharmaceuticals (SXTC) over the last 9 years, with Mar 2025 value amounting to -$114,081.

  • China SXT Pharmaceuticals' Change in Account Payables rose 11.76% to -$1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$71,329, marking a year-over-year decrease of 355.56%. This contributed to the annual value of -$114,081 for FY2025, which is 289.97% down from last year.
  • China SXT Pharmaceuticals' Change in Account Payables amounted to -$114,081 in FY2025, which was down 289.97% from -$29,254 recorded in FY2024.
  • Over the past 5 years, China SXT Pharmaceuticals' Change in Account Payables peaked at $9,700 during FY2023, and registered a low of -$619,537 during FY2021.
  • Its 3-year average for Change in Account Payables is -$44,545, with a median of -$29,254 in 2024.
  • Its Change in Account Payables has fluctuated over the past 5 years, first surged by 142.56% in 2023, then tumbled by 401.59% in 2024.
  • Over the past 5 years, China SXT Pharmaceuticals' Change in Account Payables (Yearly) stood at -$619,537 in 2021, then soared by 96.32% to -$22,792 in 2022, then surged by 142.56% to $9,700 in 2023, then plummeted by 401.59% to -$29,254 in 2024, then plummeted by 289.97% to -$114,081 in 2025.